ENTITY

Telix Pharmaceuticals (TLX AU)

Analysis

Health Care • Australia

Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.

Refresh

Company Event • 21 Feb 2025 06:00 • Upcoming

Add To Calendar

H2 2024

Company Event • 23 Aug 2024 07:00 • Latest

H1 2024

Company Event • 01 Aug 2024 07:30

Investor Update

Company Event • 22 May 2024 08:00 • Upcoming

Add To Calendar

AGM 2024 Presentation

Company Event • 05 Apr 2024 07:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00